Refractory pseudoseptic arthritis in Behçet’s disease successfully treated with infliximab: a case report and literature review

REFERENCES

• Asher B, Jorizzo J. Behget's disease. In: Firestein G, Budd R, Harris JE, McInnes I, Ruddy S, Sergent J editors. Kelley's text-book of rheumatology, 8th ed. Philadelphia, PA: Saunders Else-vier; 2009. p. 1475–80.
   Google Scholar
• Criteria for diagnosis of Behcet's disease. International Study Group for Behcet's Disease. Lancet. 1990;335:1078–80.
   PubMed Web of Science ®Google Scholar
• Zizic TM, Stevens MB. The arthropathy of Behcet's disease. Johns Hopkins Med J. 1975;136:243–50.
   PubMedGoogle Scholar
• Chamberlain MA. Behcet's syndrome in 32 patients in Yorkshire. Ann Rheum Dis. 1977;36:491–9.
   PubMed Web of Science ®Google Scholar
• Ait Badi MA, Zyani M, Kaddouri S, Niamane R, Hda A, Algayres JP. Skeletal manifestations in Behcet's disease. A report of 79 cases. Rev Med Interne. 2008; 29:277–82.
   PubMed Web of Science ®Google Scholar
• Kaklamani VG, Vaiopoulos G, Kaldamanis PG. Behcet's disease. Semin Arthritis Rheum. 1998;27:197–217.
   PubMed Web of Science ®Google Scholar
• Filali-Ansary N, Tazi-Mezalek Z, Mohattane A, Adnaoui M, Aouni M, Maaouni A, et al. Behcet disease. 162 cases. Ann Med Interne (Paris). 1999;150: 178–88.
   Google Scholar
• Yurdakul S, Yazici H, Tuzun Y, Pazarli H, Yalcin B, Altac M, et al. The arthritis of Behcet's disease: a prospective study. Ann Rheum Dis. 1983;42:505–15.
   PubMed Web of Science ®Google Scholar
• Kim HA, Choi KW, Song YW. Arthropathy in Behcet's disease. Scand J Rheumatol. 1997;26:125–9.
   PubMed Web of Science ®Google Scholar
• Gur A, Sarac AJ, Burkan YK, Nas K, Cevik R. Arthropathy, quality of life, depression, and anxiety in Behcet's disease: relationship between arthritis and these factors. Clin Rheumatol. 2006;25:524–31.
   Google Scholar
• Frikha F, Marzouk S, Kaddour N, Frigui M, Bahloul Z. Destructive arthritis in Behcet's disease: a report of eight cases and literature review. Int J Rheum Dis. 2009;12:250–5.
   Google Scholar
• Kchir MM, Zouari R, Mrad S, Haddad A, Hila A. Destructive polyarthritis in Behcet's disease. Apropos of a case and review of the literature. Rev Med Interne. 1992;13:211–4.
   PubMed Web of Science ®Google Scholar
• Duzgun N, Ates A. Erosive arthritis in a patient with Behcet's disease. Rheumatol Int. 2003;23:265–7.
   PubMed Web of Science ®Google Scholar
• Nanke Y, Kotake S, Momohara S, Tateishi M, Yamanaka H, Kamatani N. Synovial histology in three Behcet's disease patients with orthopedic surgery. Clin Exp Rheumatol. 2002;20:535–9.
   PubMed Web of Science ®Google Scholar
• Ho G Jr. Pseudoseptic arthritis. R I Med. 1994;77:7–9.
   PubMedGoogle Scholar
• Ho G Jr. Septic arthritis. In: Klippel JH, Crofford LJ, Stone JH, Weyland CM, editors. Primer on the rheumatic diseases, 12th ed. Atlanta: Arthritis Foundation; 2001. p. 259–64.
   Google Scholar
• Taarit CB, Ben Turki S, Ben Maiz H. Rheumatologic manifes-tations of Behcet's disease: report of 309 cases. Rev Med Interne. 2001;22:1049–55.
   PubMedGoogle Scholar
• Volpe A, Caramaschi P, Marchetta A, Desto E, Arcaro G. Pseudoseptic arthritis in a patient with Behcet's disease. Clin Exp Rheumatol. 2006;24:S123.
   Google Scholar
• Humby F, Gullick N, Kelly S, Pitzalis C, Oakley SP. A synovial pathergy reaction leading to a pseudo-septic arthritis and a diagnosis of Behcet's disease. Rheumatology (Oxford). 2008;47:1255–6.
   Google Scholar
• Aktulga E, Altac M, Muftuoglu A, Ozyazgan Y, Pazarli H, Tuzun Y, et al. A double blind study of colchicine in Behcet's disease. Haematologica. 1980;65:399–402.
   PubMed Web of Science ®Google Scholar
• Yurdakul S, Mat C, Tuzun Y, Ozyazgan Y, Hamuryudan V, Uysal 0, et al. A double-blind trial of colchicine in Behcet's syndrome. Arthritis Rheum. 2001;44:2686–92.
   PubMed Web of Science ®Google Scholar
• Donghi D, Mainetti C. Infliximab for the treatment of refractory Adamantiades-Behcet disease with articular, intestinal, cerebral and ocular involvement. Dermatology. 2010;220:282–6.
   PubMed Web of Science ®Google Scholar
• Andonopoulos AP, Meimaris N, Daoussis D, Bounas A, Yian-nopoulos G. Intra-articular anti-tumor necrosis factor alpha antibody in recalcitrant arthritis of Behcet's disease. Clin Exp Rheumatol. 2003;21:557–8.
   Google Scholar
• Calvo Catala J, Campos Fernandez C, Rueda Cid A, Gonzalez-Cruz Cervellera MI, Baixauli Rubio A, Pastor Cubillo MD. Efficacy of adalimumab in Behcet's disease. Description of 6 cases. Reumatol Clin. 2011;7: 258–61.
   Google Scholar
• Oppermann BP, Cote JK, Morris SJ, Harrington T. Pseudoseptic arthritis: a case series and review of the literature. Case Rep Infect Dis. 2011;2011:942023.
   PubMedGoogle Scholar
• Singleton JD, West SG, Nordstrom DM. "Pseudoseptic" arthritis complicating rheumatoid arthritis: a report of six cases. J Rheu-matol. 1991;18: 1319–22.
   Google Scholar
• Ike RW, Bole GG Jr. Pseudoseptic arthritis due to acute lipo-arthrosis in a systemic lupus erythematosus patient with osteo-necrosis. Arthritis Rheum. 2009;61:1130–2.
   PubMed Web of Science ®Google Scholar
• Louthrenoo W, Ostrov BE, Park YS, Rothfuss S, Schumacher HR Jr. Pseudoseptic arthritis: an unusual presentation of neuropathic arthropathy. Ann Rheum Dis. 1991;50:717–21.
   Google Scholar
• Pantanowitz L, Miller KB, Pihan G. Cytology of "pseudoseptic" leukemic arthritis. Acta Cytol. 2005;49:583–4.
   PubMed Web of Science ®Google Scholar
• Mann D, Schumacher HR Jr. Pseudoseptic inflammatory knee effusion caused by phagocytosis of sickled erythrocytes after fracture into the knee joint. Arthritis Rheum. 1995;38:284–7.
   PubMed Web of Science ®Google Scholar
• Perez-Ruiz F, Testillano M, Gastaca MA, Herrero-Beites AM. "Pseudoseptic" pseudogout associated with hypomagnesemia in liver transplant patients. Transplantation. 2001;71:696–8.
   Google Scholar
• McColgan BP, Borschke FA. Pseudoseptic arthritis after acci-dental intra-articular deposition of the pneumococcal polyvalent vaccine: a case report. Am J Emerg Med. 2007;25(864):e861–3.
   Google Scholar
• Roos J, Epaulard 0, Juvin R, Chen C, Pavese P, Brion JP. Acute pseudoseptic arthritis after intraarticular sodium hyaluronan. Joint Bone Spine. 2004;71:352–4.
   Google Scholar
• Korkmaz C, Kasifoglu T. Development of recurrent pseudoseptic arthritis in a patient with rheumatoid arthritis receiving TNF-alpha blocker. Joint Bone Spine. 2006;73:767–8.
   PubMed Web of Science ®Google Scholar
• Carletto A, Pacor ML, Biasi D, Caramaschi P, Zeminian S, Bellavite P, et al. Changes of neutrophil migration without modification of in vitro metabolism and adhesion in Behcet's disease. J Rheumatol. 1997;24:1332–6.
   PubMed Web of Science ®Google Scholar
• Varol A, Seifert 0, Anderson CD. The skin pathergy test: innately useful? Arch Dermatol Res. 2010;302: 155–68.
   Google Scholar
• Canete JD, Cefis R, Noordenbos T, Moll C, Gomez-Puerta JA, Pizcueta P, et al. Distinct synovial immunopathology in Behcet disease and psoriatic arthritis. Arthritis Res Ther. 2009;11:R17.
   Google Scholar
• Pineton de Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D. New insights into the pathogenesis of Behcet's disease. Autoimmun Rev. 2012;11:687–98.
   PubMed Web of Science ®Google Scholar
• Ishigatsubo Y, Samukawa S. Behcet's disease from the aspect of autoinflammatory disease. Nihon Rinsho Meneki Gakkai Kaishi. 2011;34:408–19.
   PubMedGoogle Scholar
• Demidowich AP, Freeman AF, Kuhns DB, Aksentijevich I, Galfin JI, Turner ML, et al. Genotype, phenotype, and clinical course in five patients with pyogenic arthritis, pyoderma gan-grenosum, and acne (PAPA) syndrome. Arthritis Rheum. 2012;64:2022–7.
   PubMed Web of Science ®Google Scholar
• Smith ET, Allantaz F, Bennett L, Zhang D, Gao X, Wood G, etal. Clinical, molecular, and genetic characteristics of PAPA syn-drome: a review. Curr Genomics. 2010;11:519–27.
   Google Scholar
• Vernon-Roberts B, Barnes CG, Revell PA. Synovial pathology in Behcet's syndrome. Ann Rheum Dis. 1978;37:139–45.
   PubMed Web of Science ®Google Scholar
• Gibson T, Laurent R, Highton J, Wilton M, Dyson M, Millis R. Synovial histopathology of Behcet's syndrome. Ann Rheum Dis. 1981;40:376–81.
   PubMed Web of Science ®Google Scholar
• Hatemi G, Silman A, Bang D, Bodaghi B, Chamberlain AM, Gul A, et al. EULAR recommendations for the management of Behcet disease. Ann Rheum Dis. 2008;67:1656–62.
   PubMed Web of Science ®Google Scholar
• Sfikakis PP, Markomichelakis N, Alpsoy E, Assaad-Khalil S, Bodaghi B, Gul A, et al. Anti-TNF therapy in the management of Behcet's disease—review and basis for recommendations. Rheumatology (Oxford). 2007;46:736–41.
   Google Scholar
• Accorinti M, Pirraglia MP, Paroli MP, Priori R, Conti F, Pivetti-Pezzi P. Infliximab treatment for ocular and extraocular mani-festations of Behcet's disease. Jpn J Ophthalmol. 2007;51:191–6.
   Google Scholar
• Al-Rayes H, Al-Swailem R, Al-Balawi M, Al-Dohayan N, Al-Zaidi S, Tariq M. Safety and efficacy of infliximab therapy in active Behcet's uveitis: an open-label trial. Rheumatol Int. 2008;29:53–7.
   PubMed Web of Science ®Google Scholar
• Arida A, Fragiadaki K, Giavri E, Sfikakis PP. Anti-TNF agents for Behcet's disease: analysis of published data on 369 patients. Semin Arthritis Rheum. 2011;41:61–70.
   PubMed Web of Science ®Google Scholar